Nov 26 2009
GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced the installation of Russia’s first high-definition computed tomography (CT) scanner, GE Healthcare’s flagship Discovery CT750HD, at the Center of Medical Rehabilitation by the Russian Ministry of Health in Moscow led by Professor Konstantin V. Lyadov.
The Centre of Medical Rehabilitation is the first hospital in Russia to join leading hospitals around the globe in installing this powerful groundbreaking high-definition CT technology. The scanner sets a new standard for CT clarity, allowing clinicians to diagnose quickly and confidently using significantly less x-ray radiation than previous CT scanners.
“We are delighted to have the first Discovery CT750 HD in Russia as part of Center of Medical Rehabilitation’s investment in cutting edge technology. This exciting development of high definition CT improves our ability to see fine anatomical detail in what can be difficult to image diseases,” said Professor Valentin E. Sinitsyn, Moscow Medical Academy & Head of Diagnostic Centre in Federal Medical & Rehabilitation Centre.
Vyacheslav Grischenko, General Manager Russia & CIS, GE Healthcare said: “With this outstanding technology, high-definition image quality can be achieved without increasing the x-ray dose to which patients are exposed. For some cardiac patients, for example, this can mean a valuable alternative to the traditional invasive angiogram. It is less invasive and less expensive.”
The new scanner uses a breakthrough garnet gemstone CT detector, the first new CT detector technology in 20 years. The gemstone detector can improve image clarity by up to 33% for routine body imaging and up to 47% for cardiac imaging and helps improve doctors’ ability to see the difference between various types of tissue.
In addition to providing better image clarity, the new scanner is designed to reduce the amount of X-ray dose for patients by up to 50 % for full-body scans, and up to 83% for heart scans.
The Discovery CT750 HD improves image quality while reducing dose up to 50% across the entire body, maintaining GE Healthcare’s position as a leader in low dose technology.